| Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity D Osei-Hyiaman, M DePetrillo, P Pacher, J Liu, S Radaeva, S Bátkai, ... The Journal of clinical investigation 115 (5), 1298-1305, 2005 | 1348 | 2005 |
| A biosynthetic pathway for anandamide J Liu, L Wang, J Harvey-White, D Osei-Hyiaman, R Razdan, Q Gong, ... Proceedings of the National Academy of Sciences 103 (36), 13345-13350, 2006 | 561 | 2006 |
| Evidence for novel cannabinoid receptors M Begg, P Pacher, S Bátkai, D Osei-Hyiaman, L Offertáler, FM Mo, J Liu, ... Pharmacology & therapeutics 106 (2), 133-145, 2005 | 535 | 2005 |
| Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity J Tam, VK Vemuri, J Liu, S Bátkai, B Mukhopadhyay, G Godlewski, ... The Journal of clinical investigation 120 (8), 2953-2966, 2010 | 521 | 2010 |
| Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice D Osei-Hyiaman, J Liu, L Zhou, G Godlewski, J Harvey-White, W Jeong, ... The Journal of clinical investigation 118 (9), 3160-3169, 2008 | 506 | 2008 |
| Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension S Bátkai, P Pacher, D Osei-Hyiaman, S Radaeva, J Liu, J Harvey-White, ... Circulation 110 (14), 1996-2002, 2004 | 375 | 2004 |
| Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver W Jeong, D Osei-Hyiaman, O Park, J Liu, S Bátkai, P Mukhopadhyay, ... Cell metabolism 7 (3), 227-235, 2008 | 351 | 2008 |
| Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury S Bátkai, D Osei-Hyiaman, H Pan, O El-Assal, M Rajesh, ... The FASEB journal: official publication of the Federation of American …, 2007 | 314 | 2007 |
| Dietary linoleic acid elevates endogenous 2‐AG and anandamide and induces obesity AR Alvheim, MK Malde, D Osei‐Hyiaman, YH Hong, RJ Pawlosky, ... Obesity 20 (10), 1984-1994, 2012 | 274 | 2012 |
| Cell type–dependent pro-and anti-inflammatory role of signal transducer and activator of transcription 3 in alcoholic liver injury N Horiguchi, L Wang, P Mukhopadhyay, O Park, WI Jeong, F Lafdil, ... Gastroenterology 134 (4), 1148-1158, 2008 | 196 | 2008 |
| Should peripheral CB1 cannabinoid receptors be selectively targeted for therapeutic gain? G Kunos, D Osei-Hyiaman, S Bátkai, KA Sharkey, A Makriyannis Trends in pharmacological sciences 30 (1), 1-7, 2009 | 182 | 2009 |
| Pivotal Advance: Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis M Rajesh, H Pan, P Mukhopadhyay, S Batkai, D Osei-Hyiaman, G Haskó, ... Journal of Leucocyte Biology 82 (6), 1382-1389, 2007 | 171 | 2007 |
| PPAR/RXR Regulation of Fatty Acid Metabolism and Fatty Acid ω‐Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver Disease JP Hardwick, D Osei-Hyiaman, H Wiland, MA Abdelmegeed, BJ Song PPAR research 2009 (1), 952734, 2009 | 167 | 2009 |
| Endocannabinoids and the control of energy homeostasis G Kunos, D Osei-Hyiaman, J Liu, G Godlewski, S Batkai Journal of Biological Chemistry 283 (48), 33021-33025, 2008 | 145 | 2008 |
| Cocaine-and amphetamine-related transcript is involved in the orexigenic effect of endogenous anandamide D Osei-Hyiaman, M Depetrillo, J Harvey-White, AW Bannon, BF Cravatt, ... Neuroendocrinology 81 (4), 273-282, 2005 | 137 | 2005 |
| Association of a 27-bp repeat polymorphism in ecNOS gene with ischemic stroke in Chinese patients L Hou, D Osei-Hyiaman, H Yu, Z Ren, Z Zhang, B Wang, S Harada Neurology 56 (4), 490-496, 2001 | 121 | 2001 |
| Transcriptional regulation of cannabinoid receptor-1 expression in the liver by retinoic acid acting via retinoic acid receptor-γ B Mukhopadhyay, J Liu, D Osei-Hyiaman, G Godlewski, P Mukhopadhyay, ... Journal of Biological Chemistry 285 (25), 19002-19011, 2010 | 118 | 2010 |
| The role of the endocannabinoid system in the control of energy homeostasis D Osei-Hyiaman, J Harvey-White, S Batkai, G Kunos International journal of obesity 30 (1), S33-S38, 2006 | 111 | 2006 |
| Inhibitor of fatty acid amide hydrolase normalizes cardiovascular function in hypertension without adverse metabolic effects G Godlewski, SO Alapafuja, S Bátkai, SP Nikas, R Cinar, L Offertáler, ... Chemistry & biology 17 (11), 1256-1266, 2010 | 98 | 2010 |
| Hemodynamic profile, responsiveness to anandamide, and baroreflex sensitivity of mice lacking fatty acid amide hydrolase P Pacher, S Bátkai, D Osei-Hyiaman, L Offertáler, J Liu, J Harvey-White, ... American Journal of Physiology-Heart and Circulatory Physiology 289 (2 …, 2005 | 91 | 2005 |
